Search

everythinglearnresearchcommunity

for

Search:↓

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

IGFBP5 may be a potential target for Parkinson's treatment by reducing neuron death.

Dihydrotestosterone boosts inflammation in fat cells more than testosterone.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

GLP-1 agonists may help treat certain skin conditions.

The chemicals 17βC and its methyl ester can block the effects of testosterone on hamster skin but not the effects of DHT.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

Allopregnanolone may enhance alcohol's effects on dopamine neurons, influencing addiction risk.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Activating δ-opioid receptors can help hair grow.

A single steroid injection can cause serious side effects like Cushing Syndrome.

Dopamine agonists like pramipexole and ropinirole can cause reversible hair loss.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Cortisol increases a specific protein in bone cells, which may help explain its negative effects on bone.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

TSPO might help treat anxiety and depression.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Dihydrotestosterone changes some hormone-related gene expressions in rat pituitary glands but doesn't affect the estrous cycle.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Blocking DGAT1 reduces oil gland size in mice and dogs, but only mice experience hair loss.